LIXTW
USDLixte Biotechnology Holdings Inc. Warrants
Precio en Tiempo Real
Gráfico de Precios
No hay datos de gráfico disponibles
Métricas Clave
Métricas de Mercado
Apertura
$0.030
Máximo
$0.030
Mínimo
$0.030
Volumen
N/A
Fundamentos de la Empresa
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.00M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE's Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.